@article{805ba501188c4473accddc8f2302267a,
title = "Relapse prevention in panic disorder with pharmacotherapy: where are we now?",
keywords = "antidepressants, anxiety, attacks, comorbidity, controlled-trial, discontinuation, epidemiology, follow-up, imipramine therapy, panic disorder, personalized medicine, pharmacotherapy, relapse, risk, selective serotonin reuptake inhibitors, treatment outcome, tricyclic antidepressive agents, venlafaxine, CONTROLLED-TRIAL, ATTACKS, FOLLOW-UP, COMORBIDITY, IMIPRAMINE THERAPY, Panic disorder, ANXIETY, RISK, DISCONTINUATION, EPIDEMIOLOGY",
author = "D. Caldirola and A. Alciati and S. Dacco and W. Micieli and G. Perna",
year = "2020",
month = sep,
day = "21",
doi = "10.1080/14656566.2020.1779220",
language = "English",
volume = "21",
pages = "1699--1711",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "14",
}